8T75 image
Entry Detail
PDB ID:
8T75
Keywords:
Title:
Crystal Structure of KRAS4a (GMPPNP) in complex with RAF1 (RBD-CRD)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-06-19
Release Date:
2024-02-14
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:GTPase KRas
Chain IDs:A, C, E, G
Chain Length:178
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:RAF proto-oncogene serine/threonine-protein kinase
Chain IDs:B, D, F, H
Chain Length:137
Number of Molecules:4
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CAF B CYS modified residue
Primary Citation
Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional properties.
Sci Adv 10 eadj4137 eadj4137 (2024)
PMID: 38354232 DOI: 10.1126/sciadv.adj4137

Abstact

KRAS, the most frequently mutated oncogene in human cancer, produces two isoforms, KRAS4a and KRAS4b, through alternative splicing. These isoforms differ in exon 4, which encodes the final 15 residues of the G-domain and hypervariable regions (HVRs), vital for trafficking and membrane localization. While KRAS4b has been extensively studied, KRAS4a has been largely overlooked. Our multidisciplinary study compared the structural and functional characteristics of KRAS4a and KRAS4b, revealing distinct structural properties and thermal stability. Position 151 influences KRAS4a's thermal stability, while position 153 affects binding to RAF1 CRD protein. Nuclear magnetic resonance analysis identified localized structural differences near sequence variations and provided a solution-state conformational ensemble. Notably, KRAS4a exhibits substantial transcript abundance in bile ducts, liver, and stomach, with transcript levels approaching KRAS4b in the colon and rectum. Functional disparities were observed in full-length KRAS variants, highlighting the impact of HVR variations on interaction with trafficking proteins and downstream effectors like RAF and PI3K within cells.

Legend

Protein

Chemical

Disease

Primary Citation of related structures